New ruthenium(II)/phosphines/diimines complexes: Promising antitumor (human breast cancer) and Mycobacterium tuberculosis fighting agents
Contribuinte(s) |
Universidade Estadual Paulista (UNESP) |
---|---|
Data(s) |
27/05/2014
27/05/2014
04/03/2013
|
Resumo |
The synthesis and characterization of ruthenium compounds of the type [RuCl2(P)2(N-N)] [(P)2 = (PPh3) 2, dppb = 1,4-bis(diphenylphosphino)butano; dppp = 1,3-bis(diphenylphosphino)propane; N-N = 5,5′-dimethyl-2,2′dipyridyl (5,5′-mebipy) or 4,4′-dimethyl-2,2′dipyridyl (4,4′-mebipy)] are described. The complexes were characterized using elemental analysis, UV-Vis and infrared spectroscopies, cyclic voltammetry, and X-ray crystallography. In vitro evaluation of the complexes, using the MTT methodology, revealed their cytotoxic activities in a range of 5.4-15.7 μM against the MDA-MB-231 breast tumor cells and showed that, in this case, they are more active than the reference metallodrug cisplatin. The in vitro antimycobacterial activities of the complexes had their Minimum Inhibitory Concentration (MIC) for MTB cell growth measured, by the REMA method. The MICs for these complexes were found to be between 12.5 and 25.0 μg/mL. The results are comparable with the second line drug cycloserine (MIC = 12.5-50.0 μg/mL), commonly used in the treatment of TB. © 2013 Elsevier Ltd. All rights reserved. |
Formato |
292-297 |
Identificador |
http://dx.doi.org/10.1016/j.poly.2013.01.004 Polyhedron, v. 51, n. 1, p. 292-297, 2013. 0277-5387 http://hdl.handle.net/11449/74794 10.1016/j.poly.2013.01.004 WOS:000318958700036 2-s2.0-84873434321 |
Idioma(s) |
eng |
Relação |
Polyhedron |
Direitos |
closedAccess |
Palavras-Chave | #Antimycobacterial activity #Cytotoxity #Phosphine/diimine complexes #Ruthenium(II) complexes |
Tipo |
info:eu-repo/semantics/article |